Innovision Limited: No Deviation in Fund Utilization for IPO Proceeds as of March 31, 2026
Innovision Limited reported no deviation in the utilization of IPO funds for the year ended March 31, 2026. The company raised ₹2,550 million gross via IPO on March 23, 2026. Funds were allocated to debt repayment, working capital, and general corporate purposes, with no variations reported.
This is a standard regulatory filing and does not indicate any new business developments or significant financial changes.
The announcement is a routine compliance filing confirming no deviations in fund utilization, which is a neutral outcome.
Innovision Limited has submitted a statement of deviations and variations under Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended March 31, 2026. The company raised funds through an Initial Public Offer (IPO) on March 23, 2026, with gross proceeds of ₹2,550 million (2550 Million) and net proceeds of ₹2,097.99 million (2097.99 Million).
The statement confirms that there have been no deviations or variations in the utilization of these funds. The original objects for which the funds were raised were repayment or prepayment of borrowings (₹510 million), funding working capital requirements (₹1,190 million), and general corporate purposes (₹397.99 million). The amount utilized for these purposes as of March 31, 2026, matches the allocation, with no deviation or variation reported.
A minor note indicates that ₹118 was utilized towards bank charges incurred in the monitoring agency account maintained with Kotak Bank Limited. The company has confirmed that there was no change in the terms of contracts or objects approved by shareholders, and consequently, no shareholder approval date or explanation for deviation is applicable.
What to do with a filing like this
Innovision Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Innovision Limited. Read the original for the full detail.